Pediatric Antidepressant Research Hearing
This article was originally published in The Pink Sheet Daily
The House Energy & Commerce/Oversight Subcommittee will hold a hearing on publication and disclosure issues in antidepressant pediatric clinical trials July 20
You may also be interested in...
The state attorney general alleges that GSK failed to publish information about the safety and efficacy of Paxil in children. The lawsuit seeks disgorgement of profits. GSK maintains that it has publicly communicated the data from its pediatric studies.
Although there was internal disagreement on the implications of pediatric antidepressant data, all information was reviewed publicly, the agency maintains in a letter to the House Energy & Commerce/Oversight Subcommittee.
Celgene will get exclusive use of Quanticel's single-cell genomic analysis to tweak its clinical pipeline, and it also has exclusive options to acquire the venture-backed start-up.